Pacific Edge Limited

ASX:PEB

Pacific Edge Limited

ASX:PEB
TradeAdd trade order Follow Unfollow Set Price Alert
$0.105 (+5%)
Last close price
#259
Rank
1
Held by
1
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports My Report Forum Investors
Top member reports
Consensus
No meetings
Consensus community valuation
The consensus valuation is for members only and has been removed from this chart. Click for membership options.
Become a member
Created with Highcharts 5.0.2Apr 2024May 2024Jun 2024Jul 2024Aug 2024Sep 2024Oct 2024Nov 2024Dec 2024Jan 2025Feb 2025Mar 202500.050.10.150.2
Contributing Members
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#Cancer Scare
Scoonie
Added 2 months ago
View author's company report

Yesterday PEB, the NZ headquartered and ASX listed company announced:

“Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) today notes that Novitas, the Medicare Administrative Contractor with jurisdiction for our US laboratory, on Thursday 9 January 2025 finalized a non-coverage determination that would end reimbursement for Cxbladder Triage, Detect and Monitor by Medicare”.

With the already sick PEB share price approaching stage IV terminal, on yesterdays news PEB dropped a further 60%.  Looks like PEB joins RHY (bowel cancer diagnosis), BDX (breast cancer diagnosis) and PIQ (Diabetic Kidney disease and endometriosis) as a full blown ASX Cancer Cluster. 

Sadly for everyone, no cure in sight. 

Read More